Intravitreal bevacizumab injections versus dexamethasone implant for treatment-naïve retinal vein occlusion related macular edema

Ilkka Laine1 Helsinki Retina Research Group, University of Helsinki, Helsinki;2 Unit of Ophthalmology, Kymenlaakso Central Hospital, Kotka, Finland;3 Department of Automation and Electrical Engineering, Aalto University, Helsinki, Finland

Juha-Matti Lindholm1 Helsinki Retina Research Group, University of Helsinki, Helsinki;2 Unit of Ophthalmology, Kymenlaakso Central Hospital, Kotka, Finland

Petteri Ylinen1 Helsinki Retina Research Group, University of Helsinki, Helsinki;4 Department of Ophthalmology, Helsinki University Hospital, Helsinki, Finland

Raimo Tuuminen1 Helsinki Retina Research Group, University of Helsinki, Helsinki;2 Unit of Ophthalmology, Kymenlaakso Central Hospital, Kotka, Finland;5 The Insurance Centre, Patient Insurance Centre, Helsinki, FinlandCorrespondence[email protected]

Citations (4)

Keep up to date with the latest research on this topic with citation updates for this article.

Intravitreal bevacizumab injections versus dexamethasone implant for treatment-naïve retinal vein occlusion related macular edema

Articles from other publishers (4)

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Intravitreal bevacizumab injections versus dexamethasone implant for treatment-naïve retinal vein occlusion related macular edema

Citations (4)

Articles from other publishers (4)

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date